Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kwei Ming Chen"'
Publikováno v:
Advances in Digestive Medicine. 8:33-39
Publikováno v:
Advances in Digestive Medicine. 7:207-213
Autor:
Kwei‐Ming Chen, Ming-Hui Chang, Chun-Che Lin, Tzu-Wei Yang, Ching-Pin Lin, Chi-Chih Wang, Hsuan-Yi Chen, Chia-Hsun Tsai, Ming-Chang Tsai, Kai-Fuan Yeo
Publikováno v:
Advances in Digestive Medicine. 6:62-68
Autor:
W-Hsien Kuo, Kwei-Ming Chen, Yung-Hsiang Yeh, Chi-Chieh Yang, Tsung-Hui Hu, Chih-Chao Yang, Yang-Yuan Chen, Hsiu-Hsi Chen, Yen-Po Yeh, Shiou-Shiang Chen, Shih-Chung Chen, Jun-Hung Lai, Sheng-Lei Yan, Cherng-Harng Lim, Sam Li Sheng Chen, Yu-Yu Tsao, Hsiao Hsuan Jen, Chih-Da Yao, Wei-Wen Su
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 78(4)
Rationale & Objective Hemodialysis facilities are high-risk environments for hepatitis C virus (HCV). Eliminating HCV from all dialysis facilities in a community may be achieved more effectively under a collaborative care model. Study Design Quality
Publikováno v:
Biomedical Research. 29
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a technique with high success rate for diagnosis and treatment of biliary and pancreatic diseases, but haemorrhagic complications usually occurs when utilizing Endoscopic Sphincterotomy (EST) o
Autor:
Kwei-Ming Chen, 陳奎閔
104
Introductions: A suboptimal response is common in chronic hepatitis B (CHB) patients treated with Lamivudine (LAM), Adefovir (ADV), Telbivudine (LdT) or Entecavir (ETV); either by monotherapy or combination therapy. This study is aimed to ev
Introductions: A suboptimal response is common in chronic hepatitis B (CHB) patients treated with Lamivudine (LAM), Adefovir (ADV), Telbivudine (LdT) or Entecavir (ETV); either by monotherapy or combination therapy. This study is aimed to ev
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/uy92rp
Publikováno v:
Gastroenterology. 146(4)
Publikováno v:
Gastroenterology. 146:e7-e8